期刊
AMERICAN JOURNAL OF MEDICINE
卷 132, 期 7, 页码 816-819出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2019.01.039
关键词
Beta-blockers; Cardioprotection; Coronary artery disease
Beta-blockers are commonly used medications, and they have been traditionally considered cardioprotective. Their clinical use appears to be more widespread than the available evidence base supporting their role in cardioprotection. Beta-blockers counteract neurohumoral activation in heart failure with reduced ejection fraction and offer both symptomatic improvement and reduction in adverse events. On the other hand, the use of beta-blockers in uncomplicated hypertension results in suboptimal outcomes compared to the established first-line antihypertensive agents. Providers at all levels should be familiar with common misconceptions regarding beta-blocker use in routine clinical practice. (C) 2019 Published by Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据